XIFIN, Inc., the financial cloud computing company whose platform is revolutionizing the business of healthcare diagnostics from patient to payment, today announced that it has acquired the product and service assets and related intellectual property of PathCentral, an Irvine-based technology company dedicated to the success of the worldwide pathology community.
PathCentral provides pathologists with tools to increase revenue, improve operating efficiencies, ensure patient safety and sustain a competitive advantage including AP Anywhere,® a cloud-based anatomic pathology and molecular diagnostics laboratory information system (LIS) that is the next generation of PathCentral’s eTelenext, and seamlessly integrates the critical components of a pathology practice's day-to-day operations; and PathCentralPro.net, a comprehensive online information exchange and global digital consultation forum that enables pathologists to develop new revenue streams and collaborate around the world using digital pathology technology, social media and laboratory information system functionality in a single cloud-based platform.
“The acquisition of PathCentral expands our technology platform and advances XIFIN’s vision of the open, secure exchange of diagnostic financial and clinical information,” stated Lâle White, CEO, XIFIN. “The acquisition also advances XIFIN’s ability to support the convergence of diagnostics between the laboratory, anatomic pathology, radiology and other diagnostic service providers to improve health outcomes and lower the costs of healthcare management.” PathCentral’s professional network has been rapidly gaining traction in the pathology market, with a membership that includes leading healthcare institutions such as Johns Hopkins, Massachusetts General Hospital, Penn Medicine and University of Southern California, as well as Kindstar Global, a leading provider of high-end specialty testing laboratory services in China.
PathCentralPro.net enables pathologists to upload case files using digital pathology images in a web-based setting across the campus or around the world to review and render critical secondary consult diagnoses, and provides a forum for the world’s pathologists to share cases and expand professional relationships. The network is designed to be open to all users regardless of location, consulting institution, scanning or reading technology to help improve and facilitate pathology consultation by reducing turnaround times for cancer patients and eliminating the need to move tissue samples and slides.
“This acquisition is central to XIFIN’s strategy to provide diagnostic information exchange and end-to-end connectivity between providers, payors, physicians and patients to facilitate clinical decision support and physician collaboration for emerging coordinated care models,” stated Bill Taylor, Chief Marketing Officer of XIFIN.